Hjem › Lungesykdommer › Massachusetts › Boston
Kliniske studier for Lungesykdommer i Boston, MA
14 studier for Lungesykdommer søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RekruttererFase 3
- Dana-Farber Cancer Institute, Boston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
- Brigham and Women's Hospital, Boston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
- Brigham and Women's Hospital, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Boston Medical Center, Boston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruttererFase 2
- Clinical Research Site, Boston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
RekruttererFase 2
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
RekruttererFase 2
- Research Site, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RekruttererFase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- Massachusetts General Hospital,, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutterer
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RekruttererFase 2
- Dana-Farber Cancer Institute, Boston
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Rekrutterer
- Brigham and Women's Hospital, Boston
Lungesykdommer-studier i andre byer
- Houston, TX15 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Pittsburgh, PA11 studier
- Dallas, TX10 studier
- Nashville, TN10 studier
- Columbus, OH10 studier
- Los Angeles, CA10 studier
- Washington, DC10 studier
- Miami, FL10 studier
- Ann Arbor, MI10 studier
- Chicago, IL9 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.